CatalystFDA/Bio

BIONTECH HALTS MRNA COLORECTAL CANCER VACCINE TRIAL AFTER SAFETY REVIEW - REUTERS - GNEWS

Termination of mid-stage trial signals negative efficacy data for BioNTech's mRNA cancer vaccine.

What changed

Termination of mid-stage trial signals negative efficacy data for BioNTech's mRNA cancer vaccine.

Why it matters

Termination of mid-stage trial signals negative efficacy data for BioNTech's mRNA cancer vaccine. — impact context not separately stored; see What changed.

Sources

gnews